ProAssurance (NYSE:PRA) Stock

ProAssurance

ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.

Movers_Stocks

News

Intraday Update

Markets

Movers

Trading Ideas

AHCO

DOCN

EVER

FARO

GSHD

ITRI

JBTM

Itron Posts Upbeat Results, Joins AdaptHealth, EverQuote, Goosehead Insurance And Other Big Stocks Moving Higher On Tuesday

Back,View,Of,Woman,Making,Video,Call,With,Her,Doctor

Equities

Health Care

Analyst Ratings

Insurance

General

ProAssurance adopts a defensive strategy amid rising jury verdicts and social inflation, with a 14% stock surge and a $20 price target from analyst Matthew Carletti.

ProAssurance Takes Defensive Play During Surge Of Jury Verdicts: Analyst

Earnings

Dividends

Price Target

Buybacks

Small Cap

AMSF

AMERISAFE, Inc. (NASDAQ: AMSF) is currently considered expensive on a relative basis, with the stock trading at a 22X forward 12-month price-to-earnings (P/E) ratio, which is at a premium compared with its five-year median of 20.21X and the Zacks Insurance - Accident and Health average of 13.36X.

Is AMERISAFE Stock a Pricey Pick or a Hidden Gem for Your Portfolio?

ProAssurance Corp

PRA Group Inc

PRODUCTIVITY TECHS CORP by Productivity Technologies Corp.

Productivity Technologies Corp

Northern Lights Fund Trust III PlanRock Alternative Growth ETF

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicines Inc

NEOS ETF Trust FIS Christian Stock Fund

U.S. stocks were mixed, with the Dow Jones gaining over 100 points on Tuesday.
Shares of Itron, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRI#NASDAQ">ITRI</a>) rose sharply during Tuesday's session after the company reported <a href="https://www.benzinga.com/quote/ITRI/earnings">better-than-expected fourth-quarter financial results.</a>
Itron posted quarterly earnings of $1.35 per share, beating market estimates of $1.05 per share. The company's quarterly sales came in at $612.864 million beating estimates of $603.204 million.
Additionally, the company issued FY25 EPS guidance above estimates.
Itron shares jumped 9.7% to $101.57 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>AdaptHealth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHCO#NASDAQ">AHCO</a>) shares jumped 25.4% to $10.73 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) gained 20.8% to $24.36 after the company reported better-than-expected fourth-quarter revenue results and issued first-quarter revenue guidance above estimates.</li>
<li>Dream Finders Homes, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFH#NYSE">DFH</a>) gained 19.8% to $25.16 following better-than-expected quarterly financial results..</li>
<li>FARO Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FARO#NASDAQ">FARO</a>) jumped 18.2% to $31.99 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter adjusted EPS guidance above estimates.</li>
<li>Goosehead Insurance, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) gained 16.8% to $123.48 after the company reported better-than-expected quarterly EPS and sales.</li>
<li>ProAssurance Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) jumped 15.4% to $16.28 after the company reported quarterly financial results and beat its adjusted EPS and revenue estimates.</li>
<li>JBT Marel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBTM#NYSE">JBTM</a>) gained 14.7% to $134.57 following fourth-quarter results.</li>
<li>DigitalOcean Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCN#NYSE">DOCN</a>) rose 13.5% to $42.17 after the company reported better-than-expected fourth-quarter results.</li>
<li>Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) gained 13.2% to $29.84 after the company announced first Electric SUV.</li>
<li>Stantec Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STN#NYSE">STN</a>) gained 8.6% to $82.92 following quarterly results.</li>
<li>The Home Depot, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) gained 4.5% to $399.58 after the home improvement retailer reported its fourth-quarter 2024 results and provided its 2025 outlook.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43948819/intuit-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Intuit Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Citizens Capital Markets analyst Matthew J. Carletti reiterated the Market Outperform rating on ProAssurance Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>), <a href="https://www.benzinga.com/quote/PRA/analyst-ratings" target="_blank" rel="noreferrer noopener">with a price targe of $20.</a>
The company reported on Monday fourth-quarter results, where net investment income increased 9%. Gross premiums written fell 0.5% to $207.67 million.
Carletti noted the core Specialty P&amp;C segment&#8217;s accident-year loss ratio matched expectations at 83%, reflecting continued caution around loss severity in select jurisdictions, while the Workers&#8217; Compensation segment&#8217;s loss ratio also met expectations at 77%, driven by elevated medical loss trends.
GWP in the core Specialty P&amp;C segment remained flat, in line with estimates, with cautious underwriting amidst a competitive market, solid renewal pricing (+8%), and retention (84%).
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/25/02/43938959/trump-targets-chinas-tech-sector-with-stricter-biden-era-chip-curbs-it-will-backfire-says-beijing" rel="noreferrer noopener">Trump Reportedly Targets China&#8217;s Tech Sector With Stricter Biden-Era Chip Curbs. It Will Backfire, Says Beijing</a>
The analyst wrote Workers&#8217; Compensation GWP rose by 6%, surpassing estimates mainly due to higher audit premiums, though lower new business ($3 million vs. $5 million last year) partially offset the increase.
The analyst observes that as courts cleared post-COVID-19 pandemic backlogs, a surge in large jury verdicts and social inflation emerged, prompting ProAssurance to adopt a &#8220;defense&#8221; strategy, focusing on necessary rate increases to cover elevated loss costs, which could limit near-term growth.
While frequency has declined in its workers&#8217; compensation business, severity persists.
ProAssurance&#8217;s aggressive pricing actions and constrained growth have allowed it to stay ahead of &#8220;loss cost trends,&#8221; resulting in stable loss ratios and favorable PPD levels.
The analyst noted the company was in a stronger, more stable position than a year ago and viewed the current 40%+ discount to book value as an overreaction.
PRA Price Action: ProAssurance shares traded higher by 14.10% to $16.10 at publication Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43945252/lucid-q4-earnings-preview-production-deliveries-margins-on-watch" target="_blank" rel="noreferrer noopener">Lucid Q4 Earnings Preview: Production, Deliveries, Margins On Watch</a></li>
</ul>
Photo: Ground Picture via Shutterstock

Citizens Capital Markets analyst Karol Chmiel reiterates ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) with a Market Outperform and maintains $20 price target.

Reiteration

Citizens Capital Markets Reiterates Market Outperform on ProAssurance, Maintains $20 Price Target

WIIM

ProAssurance shares are trading higher after the company reported Q4 financial results and beat its adjusted EPS and revenue estimates.

ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.17 by 111.76 percent. This is a 820 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $241.07 million which beat the analyst consensus estimate of $209.77 million by 14.92 percent. This is a 2.53 percent decrease over sales of $247.33 million the same period last year.

Earnings Beats

ProAssurance Q4 Adj EPS $0.36 Beats $0.17 Estimate, Sales $241.07M Beat $209.77M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Kosmos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KOS#NYSE">KOS</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $416.02 million. 
• Lincoln Educational Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINC#NASDAQ">LINC</a>) is estimated to report quarterly earnings at $0.29 per share on revenue of $110.85 million. 
• Summit Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) is projected to report earnings for its fourth quarter. 
• Clear Channel Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCO#NYSE">CCO</a>) is estimated to report quarterly earnings at $0.03 per share on revenue of $645.84 million. 
• BioCryst Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCRX#NASDAQ">BCRX</a>) is expected to report quarterly loss at $0.06 per share on revenue of $127.72 million. 
• Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) is expected to report quarterly earnings at $4.95 per share on revenue of $1.48 billion. 
• Gran Tierra Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GTE#AMEX">GTE</a>) is projected to report earnings for its fourth quarter. 
• Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) is likely to report quarterly earnings at $0.37 per share on revenue of $1.08 billion. 
• Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) is estimated to report quarterly earnings at $1.18 per share on revenue of $2.96 billion. 
• Owens-Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>) is likely to report quarterly earnings at $2.90 per share on revenue of $2.77 billion. 
• Fresh Del Monte Produce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDP#NYSE">FDP</a>) is expected to report quarterly earnings at $0.37 per share on revenue of $1.03 billion. 
• Kaspi.kz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSPI#NASDAQ">KSPI</a>) is estimated to report quarterly earnings at $3.35 per share on revenue of $1.52 billion. 
• Freightos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGO#NASDAQ">CRGO</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $6.46 million. 
• Azul (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZUL#NYSE">AZUL</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $1.01 billion. 
<h3>Companies Reporting After The Bell</h3>
• DMC Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) is likely to report quarterly loss at $0.29 per share on revenue of $140.50 million. 
• Ultra Clean Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) is estimated to report quarterly earnings at $0.44 per share on revenue of $559.19 million. 
• Clean Energy Fuels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNE#NASDAQ">CLNE</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $99.87 million. 
• Goosehead Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) is likely to report quarterly earnings at $0.40 per share on revenue of $78.20 million. 
• Trex Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TREX#NYSE">TREX</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $159.89 million. 
• Atlas Energy Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AESI#NYSE">AESI</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $281.61 million. 
• Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) is projected to report quarterly earnings at $0.21 per share on revenue of $469.68 million. 
• Beyond (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) is likely to report quarterly loss at $0.75 per share on revenue of $331.06 million. 
• Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) is projected to report quarterly earnings at $0.42 per share on revenue of $1.39 billion. 
• Faro Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FARO#NASDAQ">FARO</a>) is estimated to report quarterly earnings at $0.40 per share on revenue of $91.03 million. 
• Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) is likely to report quarterly loss at $0.27 per share on revenue of $130.25 million. 
• BWX Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) is likely to report quarterly earnings at $0.81 per share on revenue of $720.47 million. 
• SBA Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) is projected to report quarterly earnings at $2.22 per share on revenue of $684.39 million. 
• ONEOK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>) is estimated to report quarterly earnings at $1.55 per share on revenue of $6.77 billion. 
• Chegg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) is projected to report quarterly earnings at $0.18 per share on revenue of $142.03 million. 
• Artivion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AORT#NYSE">AORT</a>) is projected to report quarterly earnings at $0.04 per share on revenue of $101.15 million. 
• EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) is projected to report quarterly earnings at $0.39 per share on revenue of $133.83 million. 
• Cannae Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNNE#NYSE">CNNE</a>) is projected to report quarterly loss at $0.29 per share on revenue of $105.90 million. 
• Veracyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCYT#NASDAQ">VCYT</a>) is estimated to report quarterly earnings at $0.26 per share on revenue of $116.68 million. 
• Primoris Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRIM#NYSE">PRIM</a>) is estimated to report quarterly earnings at $0.76 per share on revenue of $1.59 billion. 
• Realty Income (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>) is estimated to report quarterly earnings at $1.06 per share on revenue of $1.35 billion. 
• Trip.com Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) is likely to report quarterly earnings at $0.54 per share on revenue of $1.69 billion. 
• HealthStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSTM#NASDAQ">HSTM</a>) is expected to report quarterly earnings at $0.14 per share on revenue of $73.55 million. 
• Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) is estimated to report quarterly earnings at $0.03 per share on revenue of $213.34 million. 
• Archrock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AROC#NYSE">AROC</a>) is likely to report quarterly earnings at $0.29 per share on revenue of $326.77 million. 
• Topgolf Callaway Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MODG#NYSE">MODG</a>) is likely to report quarterly loss at $0.19 per share on revenue of $885.10 million. 
• Haverty Furniture Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HVT#NYSE">HVT</a>) is likely to report quarterly earnings at $0.22 per share on revenue of $182.09 million. 
• JBT Marel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBTM#NYSE">JBTM</a>) is estimated to report quarterly earnings at $1.85 per share on revenue of $488.74 million. 
• ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $274.56 million. 
• Inspirato (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) is estimated to report quarterly loss at $1.09 per share on revenue of $58.34 million. 
• Quaker Houghton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWR#NYSE">KWR</a>) is projected to report quarterly earnings at $1.61 per share on revenue of $441.87 million. 
• Apartment Inv &amp; Mgmt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIV#NYSE">AIV</a>) is estimated to report quarterly loss at $0.12 per share on revenue of $53.10 million. 
• Navitas Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) is projected to report quarterly loss at $0.06 per share on revenue of $19.03 million. 
• Tempus AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) is projected to report quarterly loss at $0.15 per share on revenue of $200.55 million. 
• Addus HomeCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADUS#NASDAQ">ADUS</a>) is expected to report quarterly earnings at $1.35 per share on revenue of $278.36 million. 
• Helios Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLIO#NYSE">HLIO</a>) is estimated to report quarterly earnings at $0.36 per share on revenue of $175.99 million. 
• Ziff Davis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZD#NASDAQ">ZD</a>) is likely to report quarterly earnings at $2.63 per share on revenue of $424.40 million. 
• Agora (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/API#NASDAQ">API</a>) is estimated to report earnings for its fourth quarter. 
• Black Stone Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSM#NYSE">BSM</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $114.99 million. 
• LTC Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTC#NYSE">LTC</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $42.81 million. 
• Zoom Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) is projected to report quarterly earnings at $1.35 per share on revenue of $1.19 billion. 
• Douglas Dynamics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLOW#NYSE">PLOW</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $155.23 million. 
• MediaAlpha (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAX#NYSE">MAX</a>) is expected to report quarterly earnings at $0.39 per share on revenue of $289.38 million. 
• SI-BONE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIBN#NASDAQ">SIBN</a>) is projected to report quarterly loss at $0.14 per share on revenue of $46.89 million. 
• Bridge Investment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRDG#NYSE">BRDG</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $83.69 million. 
• Tortoise Capital Series Trust Tortoise Power and Energy Infrastructure Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPZ#NYSE">TPZ</a>) is expected to report earnings for its fourth quarter. 
• Offerpad Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OPAD#NYSE">OPAD</a>) is likely to report quarterly loss at $0.48 per share on revenue of $174.58 million. 
• Helix Energy Solns Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLX#NYSE">HLX</a>) is likely to report quarterly earnings at $0.09 per share on revenue of $311.66 million. 
• Public Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSA#NYSE">PSA</a>) is projected to report quarterly earnings at $4.22 per share on revenue of $1.18 billion. 
• Clearway Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWEN#NYSE">CWEN</a>) is expected to report earnings for its fourth quarter. 
• V2X (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVX#NYSE">VVX</a>) is projected to report quarterly earnings at $1.15 per share on revenue of $1.10 billion. 
• Veris Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRE#NYSE">VRE</a>) is expected to report quarterly earnings at $0.12 per share on revenue of $66.81 million. 
• GFL Environmental (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFL#NYSE">GFL</a>) is projected to report quarterly earnings at $0.23 per share on revenue of $1.98 billion. 
• Summit Hotel Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INN#NYSE">INN</a>) is projected to report quarterly earnings at $0.19 per share on revenue of $171.47 million. 
• Civitas Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIVI#NYSE">CIVI</a>) is estimated to report quarterly earnings at $1.88 per share on revenue of $1.29 billion. 
• Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) is expected to report quarterly loss at $0.44 per share on revenue of $4.54 billion. 
• Netstreit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTST#NYSE">NTST</a>) is estimated to report quarterly earnings at $0.32 per share on revenue of $43.47 million. 
• KBR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBR#NYSE">KBR</a>) is estimated to report quarterly earnings at $0.82 per share on revenue of $2.00 billion. 
• Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) is projected to report quarterly earnings at $0.42 per share on revenue of $220.06 million. 
• Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) is likely to report quarterly earnings at $3.58 per share on revenue of $3.51 billion. 
• Apple Hospitality REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APLE#NYSE">APLE</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $324.82 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADUS

AESI

AORT

APLE

AROC

AZUL

BCRX

BOOM

BRDG

BWXT

BYON

CHGG

CIVI

CLNE

CNNE

CRGO

CTRA

CWEN

FANG

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HLIO

HSTM

ISPO

KSPI

LINC

MODG

MYGN

NTST

NVTS

OPAD

PLOW

PRIM

RIOT

SBAC

SIBN

SMMT

TCOM

TREX

UCTT

VCYT

VNOM

WLKP

Earnings Scheduled For February 24, 2025

<h3>Gainers</h3>
<ul>
<li>XChange Tec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHG#NASDAQ">XHG</a>) stock increased by 27.4% to $1.44 during Monday's pre-market session. The market value of their outstanding shares is at $162.1 million. </li>
<li>Stock Yards Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYBT#NASDAQ">SYBT</a>) stock moved upwards by 27.07% to $84.62. The market value of their outstanding shares is at $2.4 billion. </li>
<li>S&amp;T Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBA#NASDAQ">STBA</a>) shares increased by 26.07% to $44.67. The market value of their outstanding shares is at $1.7 billion. </li>
<li>Hamilton Lane (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NASDAQ">HLNE</a>) stock moved upwards by 12.46% to $157.18. The market value of their outstanding shares is at $6.5 billion. </li>
<li>Powell Max (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMAX#NASDAQ">PMAX</a>) shares moved upwards by 9.72% to $2.03. The market value of their outstanding shares is at $29.8 million. </li>
<li>Greenpro Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRNQ#NASDAQ">GRNQ</a>) stock increased by 9.52% to $2.07. The company's market cap stands at $15.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>FirstCash Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCFS#NASDAQ">FCFS</a>) shares declined by 29.6% to $75.08 during Monday's pre-market session. The company's market cap stands at $3.3 billion. </li>
<li>RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) shares declined by 11.29% to $221.83. The market value of their outstanding shares is at $11.5 billion. </li>
<li>ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) stock decreased by 9.98% to $12.81. The company's market cap stands at $655.3 million. </li>
<li>Vinci Partners Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINP#NASDAQ">VINP</a>) shares fell 8.5% to $8.51. The company's market cap stands at $549.9 million. </li>
<li>Hennessy Advisors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNNA#NASDAQ">HNNA</a>) stock decreased by 8.39% to $10.6. The market value of their outstanding shares is at $82.4 million. </li>
<li>eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) shares fell 8.33% to $9.03. The company's market cap stands at $267.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EHTH

FCFS

GRNQ

HLNE

HNNA

PMAX

STBA

SYBT

VINP

12 Financials Stocks Moving In Monday's Pre-Market Session

Truist Securities analyst Mark Hughes maintains ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) with a Hold and raises the price target from $14 to $18.

Truist Securities Maintains Hold on ProAssurance, Raises Price Target to $18

ProAssurance shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.14 by 142.86 percent. The company reported quarterly sales of $285.25 million which missed the analyst consensus estimate of $316.34 million by 9.83 percent. This is a 17.67 percent increase over sales of $242.42 million the same period last year.

Earnings Misses

ProAssurance Q3 2024 Adj EPS $0.34 Beats $0.14 Estimate, Sales $285.25M Miss $316.34M Estimate

AMERISAFE, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsf#NASDAQ">AMSF</a>) is currently considered expensive on a relative basis, with the stock trading at a 22X forward 12-month price-to-earnings (P/E) ratio, which is at a premium compared with its five-year median of 20.21X and the Zacks&nbsp;Insurance - Accident and Health average of 13.36X. A premium valuation generally indicates that the market has strong confidence in the company&#39;s prospects. However, this necessitates scrutiny to determine if this higher price is warranted.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/a5/80818.jpg?v=1155545738" style="border-style:solid; border-width:1px; height:310px; width:600px" />
Image Source: Zacks Investment Research
In comparison, other insurers like&nbsp;Employers Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eig#NYSE">EIG</a>) and&nbsp;ProAssurance Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pra#NYSE">PRA</a>) are cheaper at 13.30X and 19.72X, respectively.
A brief analysis is needed to determine whether AMSF&#39;s premium valuation is justified based on its growth prospects and fundamentals.
Let&#39;s delve deeper.
Incorporated in 1985 and headquartered in DeRidder, LA, AMERISAFE currently has a market cap of $909.9 million. It is well positioned for growth, leveraging rising investment income and a robust balance sheet.
AMSF&#39;s extensive experience in hazardous industries and a high policy retention rate are major positives. Its cost-saving initiatives are expected to support its bottom line. Last year, it lowered loss and loss adjustment expenses by 2.7%.
The long time lag between receiving premiums and settling claims allows the company to invest funds for extended periods, compounding returns more effectively than insurers with quicker claim payouts, thereby boosting its investment income potential. Last year, it recorded a net investment income of $31.3 million, which advanced by 15.1%, resulting from increased fixed-income reinvestment rates. The first half of 2024 also witnessed higher reinvestment rates.
AMSF&#39;s solid balance sheet, with no debt and $884.2 million in investments and cash as of June 30, 2024, supports initiatives to boost shareholder value. The company raised its quarterly dividend by 8.8% in February 2024, continuing its steady dividend payments since 2013. In the second quarter, AMERISAFE repurchased $4.1 million worth of shares, with $6.3 million remaining in its buyback program as of June 30.
<h2>Should Investors Pay the Premium for AMSF?</h2>
The factors mentioned above have contributed to AMERISAFE&#39;s premium valuation, reflecting strong investor confidence in its future growth and profitability. As a result, investors are willing to pay a higher price for the stock, anticipating that it will outperform both its industry peers and the broader market in the coming months.
However, uncertainty surrounds the stock due to AMERISAFE&#39;s continuous decline in net premiums earned over the past five years. If this trend persists, it could potentially impede the company&#39;s ability to enhance its profits. The Zacks Consensus Estimate for 2024 earnings is pegged at $2.40 per share, indicating a 17.5% year-over-year decline. The same for 2025 signals a further 12.5% fall.
Also, AMERISAFE has faced a downward trend in free cash flow from 2018 to 2022, indicating potential operational challenges. While it saw a 12.2% increase in 2023, the sustainability of this growth is uncertain. In the trailing 12 months, free cash flow dropped sharply by 56.7%, raising concerns about the company&#39;s long-term financial health.
Despite these headwinds, the company&#39;s overall outlook remains positive. Leading brokers have raised AMSF&#39;s short-term price target by 12.47% from its recent closing price of $47.72, with the highest target set at $65, representing a potential upside of 36.21%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/06/80819.jpg?v=1182891382" style="border-style:solid; border-width:1px; height:315px; width:600px" />
Image Source: Zacks Investment Research
Existing investors should hold onto AMERISAFE stock to capitalize on its upward price movement. However, new investors might want to wait for a better entry point. Currently, the stock has a Zacks Rank #3 (Hold) and appears overvalued, suggesting that it may not be the ideal time to buy. Waiting for a more attractive valuation could present a better opportunity to invest.
<a href="https://www.zacks.com/stock/news/2347764/is-amerisafe-stock-a-pricey-pick-or-a-hidden-gem-for-your-portfolio?cid=CS-BENZ-FT-analyst_blog|rank_focused-2347764">To read this article on Zacks.com click here.</a>

Shares of NMI Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmih#NASDAQ">NMIH</a>) have rallied 28.9% year to date, outperforming the industry&#39;s increase of 24.6%, the Finance sector&#39;s increase of 11.6% and the S&amp;P 500 composite&#39;s rise of 17.5%.
An improving mortgage insurance portfolio, higher new insurance written volume, a comprehensive reinsurance program, its solid capital position and effective capital deployment drive this Zacks Rank #2 (Buy) stock.
This mortgage insurer has a decent history of delivering surprises in the last six quarters.
NMIH&#39;s return on equity (ROE) for the trailing 12 months is 18.3%, better than the industry average of 8%. This reflects efficiency in utilizing its shareholders&#39; funds. It targets 13% ROE over the medium term.
Also, the return on invested capital in the trailing 12 months was 14.8%, better than the industry average of 6.1%, which reflected the insurer&#39;s efficiency in utilizing funds to generate income.
The Zacks Consensus Estimate for NMI Holdings&#39; 2024 and 2025 earnings has moved 4.7% and 2.6% north, respectively, in the past 30 days, reflecting analyst optimism.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/52/74926.jpg?v=778876063" />
Image Source: Zacks Investment Research
<h3>Can NMIH Retain the Momentum?</h3>
Per the Federal Reserve, the U.S. residential mortgage market is one of the largest in the world, with nearly $13 trillion of mortgage debt outstanding as of Dec 31, 2023, and includes both primary and secondary components. NMIH stands to gain from new business opportunities from a growing mortgage insurance market.&nbsp;NMI Holdings&#39; mortgage insurance portfolio is expected to create a strong foundation for future earnings.
Growth in monthly and single premium policy production is tied to the increased penetration of existing customer accounts. New customer account activation will also drive results.
In order to enhance its return profile, absorb losses, provide efficient growth capital and mitigate the impact of credit volatility, NMIH has a comprehensive reinsurance program for its in-force portfolio.
To drive margin expansion, NMIH remains focused on efficiency and expense management.
NMIH engages in share buybacks and has a $124.9 million share repurchase program under its kitty.
All these together should help the insurer continue to generate solid mid-teens shareholders&#39; returns.
The Zacks Consensus Estimate for NMI Holdings&#39; 2024 earnings is pegged at $4.44, which indicates a 15.6% increase from the year-ago reported figure on 11.8% higher revenues of $647.1 million. The consensus estimate for 2025 earnings per share is pegged at $4.69, which implies a 5.6% increase year over year on 6.5% higher revenues of $689 million.
The expected long-term growth rate is pegged at 9.8%. Notably, earnings grew 18.7% in the past five years, better than the industry average of 10.5%. NMI Holdings&#39; superior primary insurance in-force portfolio generates industry-leading growth. &nbsp;
<h3>Attractive Valuation</h3>
NMIH&#39;s shares are trading at a price-to-book multiple of 1.49, lower than the industry average of 1.56. Before valuation expands, it is wise to take a position in the stock.
This insurer has a Value Score of B, reflecting an attractive valuation.&nbsp; Back-tested results have shown that stocks with a Value Score of A or B combined with a Zacks Rank #1 (Strong Buy) or #2 offer superior returns.
<h3>Other Stocks to Consider</h3>
Some other top-ranked stocks from the insurance industry are Heritage Insurance (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hrtg#NYSE">HRTG</a>), Axis Capital Holdings (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axs#NYSE">AXS</a>) and ProAssurance Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pra#NYSE">PRA</a>), each sporting a Zacks Rank #1 (Strong Buy).
Heritage Insurance earnings surpassed estimates in three of the last four quarters and missed in one, the average beat being 49.15%. Year to date, HRTG has rallied 132.4%.
The Zacks Consensus Estimate for HRTG&#39;s 2024 and 2025 earnings implies 10.3% and 18.1% year-over-year growth, respectively.
Axis Capital earnings surpassed estimates in each of the last four quarters, the average earnings surprise being 94.62%. Year to date, AXS&#39; stock has surged 35.1%.
The Zacks Consensus Estimate for AXS&#39; 2024 and 2025 earnings indicates 8.3% year-over-year growth each.
ProAssurance earnings surpassed estimates in two of the last four quarters and missed in the other two. Year to date, PRA&#39;s stock has lost 2.6%.
The Zacks Consensus Estimate for PRA&#39;s 2024 and 2025 earnings suggests 457.1% and 49.2% year-over-year growth, respectively.
<a href="https://www.zacks.com/stock/news/2325241/nmi-holdings-nmih-surges-29-ytd-will-the-rally-last?cid=CS-BENZ-FT-analyst_blog|price_surge_/_plunge-2325241">To read this article on Zacks.com click here.</a>

Mid Cap

Federal Reserve

HRTG

NMIH

NMI Holdings Surges 29% YTD: Will the Rally Last?

Truist Securities analyst Mark Hughes maintains ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) with a Hold and lowers the price target from $16 to $14.

Truist Securities Maintains Hold on ProAssurance, Lowers Price Target to $14

ProAssurance shares are trading higher after the company reported better-than-expected Q2 financial results.

ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.10 by 130 percent. This is a 64.29 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $239.867 million which beat the analyst consensus estimate of $239.598 million by 0.11 percent. This is a 3.23 percent decrease over sales of $247.862 million the same period last year.

ProAssurance Q2 2024 Adj. EPS $0.23 Beats $0.10 Estimate, Sales $239.867M Beat $239.598M Estimate

ProAssurance Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pra#NYSE">PRA</a>) is set to report its second-quarter 2024 results on Aug 8, after the closing bell.
The Zacks Consensus Estimate for second-quarter earnings is currently pegged at 8 cents per share, implying a decline of 50% from the year-ago reported number. The estimate remained stable over the past month. The Zacks Consensus Estimate for second-quarter revenues is currently pegged at almost $273.7 million, suggesting a 3.1% fall from the year-ago actuals.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/b7/73610.jpg?v=1011417650" style="border-style:solid; border-width:1px; height:310px; width:600px" />
Image Source: Zacks Investment Research
ProAssurance beat the consensus estimate for earnings in two of the trailing four quarters and missed twice, with the average surprise being negative 42.9%, as you can see below.
<div class="chart_embed">
<h3>ProAssurance Corporation Price and EPS Surprise</h3>
<img alt="ProAssurance Corporation Price and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/76/1723034329.png" style="border-style:solid; border-width:1px; height:310px; width:600px" title="" />
ProAssurance Corporation price-eps-surprise | ProAssurance Corporation Quote
</div>
<h3>Q2 Earnings Whispers</h3>
Our proven model does not conclusively predict an earnings beat for ProAssurance this time around. The combination of a positive&nbsp;Earnings ESP&nbsp;and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. That is not the case here, as you will see below.
Earnings ESP: The company has an Earnings ESP of 0.00%. This is because the Most Accurate Estimate currently stands at 8 cents per share, in line with the Zacks Consensus Estimate.
Zacks Rank: ProAssurance currently carries a Zacks Rank #3.
Now, let&#39;s see how things have shaped up before the second-quarter earnings announcement.
<h3>Q2 Key Predictions</h3>
ProAssurance&#39;s second-quarter results are expected to have been affected by lower premiums, weaker contributions from the segments and deteriorating ratios. The negatives are likely to have been partially offset by growth in investment income.
The Zacks Consensus Estimate for net premiums earned indicates a 5.2% year-over-year decline, whereas our estimate suggests a 6.1% fall. The consensus mark for Specialty P&amp;C Segment&#39;s operating loss is pegged at $14.3 million, while our model estimate stands at a loss of $12.9 million.
Similarly, the consensus estimate for Workers&#39; Compensation operating loss is pegged at $6.4 million, wider than the year-ago level of $2.5 million. Also, the consensus estimate and our model estimate for Segregated Portfolio Cell Reinsurance&#39;s profits indicate around 36% year-over-year fall. The renewal rate is expected to have declined in the second quarter.
The consensus mark for the combined ratio is pegged at 112.35%, while our estimate suggests 112.37% compared with the year-ago level of 108.20%. A higher combined ratio suggests that the company has less premium left after claim settlements.
The consensus mark for the underwriting expense ratio is pegged at 31.62%, while our estimate stands at 31.91% compared with the year-ago level of 31.10%. These factors are expected to have positioned the company for a year-over-year decline in profits, making an earnings beat uncertain.
Nevertheless, higher investment income due to the high-interest rate environment is likely to have provided some breathing room. The Zacks Consensus Estimate for net investment income indicates an 8.9% year-over-year increase, while our estimate suggests 8.1% growth.
<h3>Price Performance</h3>
ProAssurance&#39;sstock has lost 16.2% year to date, against the industry&#39;s rally of 17.3%. The S&amp;P 500 Index registered a 10% gain during this time. In comparison, its peers like Universal Insurance Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uve#NYSE">UVE</a>) and Ambac Financial Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ambc#NYSE">AMBC</a>) increased 16.9% and decreased 36.9%, respectively, during the same period.
<h3>YTD Price Performance</h3>
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/d5/73611.jpg?v=1673120884" style="border-style:solid; border-width:1px; height:310px; width:600px" />
Image Source: Zacks Investment Research
<h3>What Should Investors Do Now?</h3>
Given ProAssurance&#39;s cost-control and inorganic growth efforts and rising investment income, current investors may consider holding onto the stock and closely monitoring the upcoming earnings results. The decline in stock price has improved its valuation as compared with the industry average. However, it faces several challenges, including increasing competition, an anticipated decline in premiums and profits and a high leverage ratio. These headwinds suggest that new investors might want to wait and observe how the company navigates these challenges before making any investment decisions.
<a href="https://www.zacks.com/stock/news/2318163/proassurance-pra-q2-earnings-profit-climb-or-slippery-slope?cid=CS-BENZ-FT-analyst_blog|earnings_preview-2318163">To read this article on Zacks.com click here.</a>

AMBC

ProAssurance Q2 Earnings: Profit Climb or Slippery Slope?

ProAssurance (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pra#NYSE">PRA</a>) shares soared 12.6% in the last trading session to close at $13.16. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock&#39;s 4.2% loss over the past four weeks.
Increased optimism around the accelerated growth in new business is driving the stock. This is expected to boost premium levels in the near future. The company&#39;s Specialty P&amp;C Segment and Workers&#39; Compensation Insurance businesses are likely to be key growth drivers. Additionally, the company&#39;s focus on cost-control measures is expected to improve its margins, further enhancing its financial performance.
This medical professional liability insurer is expected to post quarterly earnings of $0.08 per share in its upcoming report, which represents a year-over-year change of -50%. Revenues are expected to be $273.65 million, down 3.1% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For ProAssurance, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock&#39;s price usually doesn&#39;t keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on PRA going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #1 (Strong Buy).
ProAssurance is a member of the Zacks Insurance - Property and Casualty industry. One other stock in the same industry, Root, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/root#NASDAQ">ROOT</a>), finished the last trading session 5.5% lower at $63.40. ROOT has returned 30.3% over the past month.
For Root, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$1.74. This represents a change of +31.8% from what the company reported a year ago. Root currently has a Zacks Rank of #1 (Strong Buy).
<a href="https://www.zacks.com/stock/news/2313219/proassurance-pra-moves-12-6-higher-will-this-strength-last?cid=CS-BENZ-FT-tale_of_the_tape|daily_price_change_5%-2313219">To read this article on Zacks.com click here.</a>

ROOT

ProAssurance Moves 12.6% Higher: Will This Strength Last?

First American Financial (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/faf#NYSE">FAF</a>) is poised to grow, given the increased demand among millennials for first-time home purchases. The expansion of its valuation and data businesses, as well as strength in commercial business and technological upgrades, is expected. These, along with solid growth projections, make the Zacks rank #3 (Hold) stock worth retaining.
<h3>An Outperformer</h3>
Shares have gained 8.5% in the past month, outperforming the industry&#39;s growth of 7.6%, the Finance sector&#39;s decline of 1% and the Zacks S&amp;P 500 composite&#39;s increase of 0.7%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/ff/71942.jpg?v=482038030" /> 
Image Source: Zacks Investment Research
<h3>Optimistic Growth Projection</h3>
The Zacks Consensus Estimate for 2024 earnings is pegged at $3.83, indicating an increase of 0.8% on 4.7% higher revenues of $6.3 billion. The consensus estimate for 2025 earnings is pegged at $5.12, indicating an increase of 33.8% on 10.2% higher revenues of $6.9 billion. 
We expect 2026 EPS to witness a three-year CAGR of 11.3%.
<h3>Return on Equity</h3>
Return on equity (ROE) is a measure of profitability, reflecting how efficiently a company is utilizing its shareholders&#39; funds. FAF&#39;s trailing 12-month ROE of 8.2% outperformed the industry average of 7.8%. &nbsp;
<h3>Growth Drivers</h3>
An increased demand for first-time home purchases among millennials continues to drive results at First American. It expects housing demand, improving economy and labor markets to drive home price appreciation. Thus, banking on growing leadership in title data, courtesy of proprietary data extraction, sturdy distribution relationships, prudent underwriting and continued investments in technology, FAF remains well poised for long-term growth.
Growing direct premiums, escrow fees and title agent premiums should continue to drive the top line. We expect the 2026 top line to increase at a three-year CAGR of 8.2%.
Strategic initiatives to strengthen its product offerings, intensify the company&#39;s focus on its core business and expand FAF&#39;s valuation and data businesses bode well. Also, the expansion of title plant assets and the upgrade of technology solutions drive increased efficiency.
<h3>Impressive Dividend History and Share Buyback Plans</h3>
First American has a solid track record of dividend increase, with the metric witnessing an eight-year (2016-2024) CAGR of 8.2%. FAF&#39;s dividend yield of 3.9% compares positively with the industry average of 0.3%.
The company also engaged in share buyback and had $210.4 million remaining under its authorization as of Mar 31, 2024.
<h3>Risks</h3>
Despite the upside potential, there are a few factors that investors should keep an eye on. A challenging real estate and mortgage industry weigh on First American. Transaction volumes suffer due to higher mortgage rates and slow inventory growth. A tough mortgage origination market is a concern.
Also, as the Fed intends to lower rates, the company estimates that for each 25-basis point decline in the Fed funds rate, the annualized investment income will decline $15 million. But the ultimate amount will fluctuate depending on the level of cash and escrow balances.
First American&#39;s debt levels have been increasing in the past few years, with the debt-to-capital ratio deteriorating. Its times interest earned compares unfavorably with the industry average.&nbsp;
<h3>Stocks to Consider</h3>
Some top-ranked stocks from the insurance industry are RLI Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rli#NYSE">RLI</a>), Palomar Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plmr#NASDAQ">PLMR</a>) and ProAssurance Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pra#NYSE">PRA</a>). Each stock presently sports a Zacks Rank&nbsp;#1 (Strong Buy).
RLI Corporation&#39;s earnings surpassed estimates in three of the last four quarters while missing in one, the average beat being 132.39%. Year to date, shares of RLI have gained 8.2%.
The Zacks Consensus Estimate for RLI&#39;s 2024 and 2025 earnings implies 18.2% and 4.1% year-over-year growth, respectively.
Palomar&#39;s earnings surpassed estimates in each of the last four quarters, the average earnings surprise being 15.10%. Year to date, PLMR&#39;s stock has surged 65.8%.
The Zacks Consensus Estimate for PLMR&#39;s 2024 and 2025 earnings indicates 26.3% and 18.5% year-over-year growth, respectively.
ProAssurance earnings surpassed estimates in two of the last four quarters and missed in the other two. Year to date, PRA&#39;s stock has lost 12.4%.
The Zacks Consensus Estimate for PRA&#39;s 2024 and 2025 earnings implies 371.4% and 72.6% year-over-year growth, respectively.
<a href="https://www.zacks.com/stock/news/2305535/here-s-why-wait-see-style-is-apt-for-first-american-faf?cid=CS-BENZ-FT-analyst_blog|rank_focused-2305535">To read this article on Zacks.com click here.</a>

PLMR

Here's Why Wait & See Style Is Apt for First American

JMP Securities analyst Matthew Carletti maintains ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) with a Market Outperform and lowers the price target from $22 to $20.

JMP Securities Maintains Market Outperform on ProAssurance, Lowers Price Target to $20

Cincinnati Financial Corporation&#39;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cinf#NASDAQ">CINF</a>) higher level of insured exposure, rate increase, agent-focused business model, consistent cash flow and a solid capital position make it worth retaining in one&#39;s portfolio.
It has a solid history of delivering positive surprises in the last five quarters. Earnings of this Zacks Rank #3 (Hold) insurer grew 11.9% in the last five years, better than the industry average of 10.5%.
CINF has a VGM Score of B. The Zacks Consensus Estimate for 2025 earnings per share has moved 1 cent north in the past 30 days, reflecting analyst optimism.
Shares have gained 12.8% year to date, compared with the industry&#39;s increase of 13.9%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/d8/70799.jpg?v=624595373" />
Image Source: Zacks Investment Research
<h3>Return on Equity</h3>
CINF has a return on equity (&quot;ROE&quot;) of 9.3%, better than the industry average of 7.8%. ROE measures how efficiently a company utilizes shareholders&#39; funds to generate profit.
<h3>Optimistic Growth Projection</h3>
The Zacks Consensus Estimate for 2024 earnings stands at $6.32 per share, suggesting an increase of 4.8% on 10.7% higher revenues of $9.8 billion. The consensus estimate for 2025 earnings per share stands at $6.99, suggesting an increase of 10.7% on 8.5% higher revenues of $10.7 billion.
The long-term earnings growth is expected to be 7.3%. We expect the 2026 bottom line to witness a three-year CAGR of 6.5%.
<h3>Business Tailwinds</h3>
Prudent pricing, an agent-centric model, a higher level of insured exposures and disciplined expansion of Cincinnati Re should benefit premiums, the primary driver of an insurer&#39;s top line. We expect 2026 net earned premiums to witness a three-year CAGR of 8.5%. CINF boasts above-average industry premium growth.
The Excess and Surplus line has been performing well since its inception in 2008. This segment should continue to benefit from new business written, higher renewal written premiums and higher average renewal estimated pricing. Technology and data are also being used to identify new exposures in emerging businesses.
Improving interest income from fixed-maturity securities and a decrease in equity portfolio dividends in an improved rate environment should drive net investment income.
Notably, its free cash flow conversion has remained more than 150% over the last many quarters, reflecting its solid earnings.
<h3>Risks</h3>
Despite the upside potential, there are a few factors that investors should keep an eye on.
Being a property and casualty insurer, CINF is exposed to catastrophe losses, inducing volatility in its underwriting profitability. Nonetheless, banking on prudent underwriting, CINF&#39;s solid track record of 34 years of favorable reserve development is appreciable. It also has a reinsurance program to limit insured loss.
CINF has been witnessing an increase in expenses over the past many years due to a rise in insurance loss and policyholder benefits as well as underwriting, acquisition and insurance expenses, resulting in margin contraction. We expect expenses to increase 10.3% in 2024. Net margin is expected to contract 292 basis points in the same year.
<h3>Impressive Dividend History</h3>
Banking on operational efficiency that ensures continuous cash flows, this insurer boasts increasing dividends for 64 straight years. Its dividend yield of 2.8% is better than the industry average of 0.3%, making the stock an attractive pick for yield-seeking investors.&nbsp; Given the board&#39;s positive outlook and confidence in outstanding capital, liquidity and financial flexibility, we expect the momentum to continue.
<h3>Stocks to Consider</h3>
Some top-ranked stocks from the insurance industry are HCI Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hci#NYSE">HCI</a>), Palomar Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plmr#NASDAQ">PLMR</a>) and ProAssurance (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pra#NYSE">PRA</a>), each sporting a Zacks Rank #1 (Strong Buy).
HCI Group earnings surpassed estimates in each of the last four quarters, the average beat being 139.15%. In the past year, HCI has rallied 45.7%.
The Zacks Consensus Estimate for HCI&#39;s 2024 and 2025 earnings implies 57.6% and 4.3% year-over-year growth, respectively.
Palomar&#39;s earnings surpassed estimates in each of the last four quarters, the average earnings surprise being 15.10%. In the past year, PLMR&#39;s stock has surged 45.5%.
The Zacks Consensus Estimate for PLMR&#39;s 2024 and 2025 earnings indicates 26% and 18% year-over-year growth, respectively.
ProAssurance earnings surpassed estimates in two of the last four quarters and missed in the other two. In the past year, PRA&#39;s stock has lost 28.1%.
The Zacks Consensus Estimate for PRA&#39;s 2024 and 2025 earnings suggests 371.4% and 72.6% year-over-year growth, respectively.
<a href="https://www.zacks.com/stock/news/2298723/here-s-why-you-should-retain-cincinnati-financial-cinf-stock?cid=CS-BENZ-FT-analyst_blog|rank_focused-2298723">To read this article on Zacks.com click here.</a>

CINF

Here's Why You Should Retain Cincinnati Financial Stock

Press Releases

ProAssurance Announces Dates for Release of First Quarter 2024 Results Release and Investor Teleconference

ProAssurance Reports Results for First Quarter 2024

ProAssurance Announces Election of Richard J. Bielen, C.P.A., and Staci M. Pierce, J.D., to Board

ProAssurance to Announce Second Quarter 2024 Results on Thursday, August 8, 2024

ProAssurance Reports Results for Second Quarter 2024

abrdn Income Credit Strategies Fund 5.25% Series A Perpetual Preferred Shares Declare Quarterly Dividend

ProAssurance to Announce Third Quarter 2024 Results on Thursday, November 7, 2024

ProAssurance Reports Results for Third Quarter 2024

ProAssurance to Announce Fourth-Quarter and Full-Year 2024 Results on Monday, February 24, 2025

Comments

ProAssurance

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga